References
Lamm DL (2000) Efficacy and safety of bacille Calmette-Guérin immunotherapy in superficial bladder cancer. Clin Infect Dis 31 (Suppl 3):86–90
Elkabani M, Greene JN, Vincent AL et al. (2000) Cancer Control 7:476–481
Gonzalez OY, Musher DM, Brar I et al. (2003) Spectrum of Bacille Calmette-Guérin (BCG) infection after intravesical BCG immunotherapy. Clin Infect Dis 36:140–148
DeHaven JI, Traynelis C, Riggs DR et al. (1992) Antibiotic and steroid therapy of massive systemic bacillus Calmette-Guérin instillation. J Urol 147:738–742
Hunt BJ, Andrews V, Pettingale KW (1987) The significance of pancytopenia in miliary tuberculosis. Post Grad Med J 63:801–804
Durek C, Rusch-Gerdes S, Jocham D, Bohle A (2000) Sensitivity of BCG to modern antibiotics. Eur Urol 37 (Suppl 1):21–25
Preheim LC (1999) Other nontuberculous mycobacteria and Mycobacterium bovis. In: Schlossberg (ed) Tuberculosis and nontuberculous mycobacterial infections. Saunders, Philadelphia, p 399
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Toscano Rico, M., Machado, J., Cardoso, O. et al. Severe Disseminated Tuberculosis After Intravesical Instillation of Bacillus Calmette-Guérin. Eur J Clin Microbiol Infect Dis 22, 447–448 (2003). https://doi.org/10.1007/s10096-003-0955-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-003-0955-x